Biocon Limited
BIOCON
Ранг среди акций
#3386
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Цена акции
$3.75
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$5.13B
Изменение (1 день)
-2.30%
Изменение (1 год)
-9.49%
Страна
IN
Торговля Biocon Limited (BIOCON)
Категория
Healthcare
Прибыль Biocon Limited (BIOCON)
Прибыль на Jun 2026 TTM: $52.82M
Согласно последним финансовым отчетам Biocon Limited, текущая прибыль компании составляет $52.82M. В 2024 году компания получила прибыль $182.91M, больше, чем прибыли за 2023, которая составила $109.16M. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании Biocon Limited с 2004 по 2026
Прибыль в конце каждого года
| Год | Прибыль | Изменить |
|---|---|---|
| 2026 (TTM) | $52.82M | -76.06% |
| 2025 | $220.59M | 20.60% |
| 2024 | $182.91M | 67.56% |
| 2023 | $109.16M | -15.71% |
| 2022 | $129.51M | -11.21% |
| 2021 | $145.85M | -9.56% |
| 2020 | $161.27M | -7.82% |
| 2019 | $174.96M | 86.74% |
| 2018 | $93.69M | -28.50% |
| 2017 | $131.03M | 15.54% |
| 2016 | $113.40M | 13.38% |
| 2015 | $100.02M | -3.94% |
| 2014 | $104.12M | -7.29% |
| 2013 | $112.30M | 45.09% |
| 2012 | $77.40M | -22.86% |
| 2011 | $100.34M | 28.22% |
| 2010 | $78.26M | 52.81% |
| 2009 | $51.21M | -11.25% |
| 2008 | $57.70M | 18.55% |
| 2007 | $48.67M | 7.03% |
| 2006 | $45.48M | -7.69% |
| 2005 | $49.26M | 32.27% |
| 2004 | $37.24M | 0.00% |
Прибыль схожих компаний или конкурентов
| Компания | Прибыль | Разница в прибыли | Страна |
|---|---|---|---|
| $5.27B | 9,886.99% |
US
|
|
| $-3.09B | -5,944.63% |
US
|
|
| $-4.02B | -7,703.88% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | 3,593.17% |
NL
|
